GeneDx Holdings
223 hedge funds and large institutions have $2.17B invested in GeneDx Holdings in 2026 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 85 increasing their positions, 58 reducing their positions, and 71 closing their positions.
143% more call options, than puts
Call options by funds: $64.8M | Put options by funds: $26.6M
47% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 58
0.34% less ownership
Funds ownership: 106.7% → 106.36% (-0.34%)
3% less capital inflows, than outflows
Capital inflows: $515M | Capital outflows: $532M
7% less funds holding
Funds holding: 241 → 223 (-18)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
23% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 71
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Corvex Management
New York
|
+$88.5M |
| 2 |
CC
Casdin Capital
New York
|
+$39.8M |
| 3 |
Deep Track Capital
Greenwich,
Connecticut
|
+$39.8M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$35.5M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$30.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$87.9M |
| 2 |
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$30.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$29.6M |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$27.7M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$24.9M |
WGS Hedge Fund Activity: Q2 2026 in Review
223 of the 8,355 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2026, worth a combined $2.17B — up 8% from $2.01B a quarter earlier.
Sellers outnumbered buyers: 71 funds closed out of WGS and 55 opened new positions — a net loss of 16 holders — while 58 trimmed existing stakes and 85 added.
The largest buyer was Corvex Management, adding an estimated $88.5M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $87.9M sold.
- 223 institutional investors held GeneDx Holdings (WGS) as of Q2 2026, down from 241 in Q1 2026.
- Funds reported $2.17B of GeneDx Holdings stock for Q2 2026, up 8% quarter-over-quarter.
- 55 funds opened new GeneDx Holdings positions in Q2 2026 and 71 closed out, a net change of -16 holders.
- The largest GeneDx Holdings buyer in Q2 2026 was Corvex Management, an estimated $88.5M added.
- The largest GeneDx Holdings seller in Q2 2026 was Westfield Capital Management, an estimated $87.9M sold.
Based on aggregated 13F filings for Q2 2026.